Placebo matching active ingredient. Encapsulated tablets.

DRUG2 trials

Sponsors

Helse Bergen HF, St. Olavs Hospital HF

Conditions

chronic cluster headacheepisodic cluster headache

Phase 3

A multicenter, phase 3, randomized, placebo-controlled, triple-blind crossover study of candesartan for prevention of chronic cluster headache (Chronic CandClus2)

Not yet recruitingCTIS2025-521529-34-00

Helse Bergen HF, St. Olavs Hospital HFchronic cluster headache

Target: 44Updated: 2025-11-05

A phase 3 randomized, placebo-controlled, triple blind parallel-group study of candesartan in adults with episodic cluster headache (Episodic CandClus2)

Not yet recruitingCTIS2025-521470-34-00

Helse Bergen HF, St. Olavs Hospital HFepisodic cluster headache

Target: 83Updated: 2025-11-05